Abstract
The aim of this review is to summarize the current magnetic resonance imaging (MRI) variants applied on the studies of Alzheimer’s disease (AD). Experimental findings, advantages and disadvantages, and the prospect of every individual technique will be presented. MRI can be used to investigate the change of the brain in terms of volume, function, white matter track orientation and even mechanical properties and metabolic concentration.Results from volumetric and morphological analysis indicated that the hippocampus reduced by approximately 18%-24% or 3%-4% annually. Functional MRI (fMRI) detected the blood oxygen level dependent (BOLD) signaland suggested thatmedial temporal lobe (MTL) such as hippocampus and entorhinal cortex reduced at the early stage of AD, and frontal, temporal, and parietal cortices at the later stage. In diffusion tensor imaging (DTI), the white matter fiber track integrity is measured but the results are inconsistent. Besides,magnetic resonance spectroscopy (MRS), chemical shift imaging (CSI), arterial spin labeling (ASL), magnetic resonance elastography (MRE) and susceptibility weighted imaging (SWI) will also be included in this review.
Keywords: Alzheimer’s disease, Multimodal MRI, fMRI, DTI, MRS, amyloid, tau pathology.
Current Alzheimer Research
Title:Application of Multimodal MR Imaging on Studying Alzheimer's Disease: A Survey
Volume: 10 Issue: 8
Author(s): Defeng Wang, Steve CN Hui, Lin Shi, Wen-hua Huang, Tianfu Wang, Vincent CT Mok, Winnie CW Chu and Anil T Ahuja
Affiliation:
Keywords: Alzheimer’s disease, Multimodal MRI, fMRI, DTI, MRS, amyloid, tau pathology.
Abstract: The aim of this review is to summarize the current magnetic resonance imaging (MRI) variants applied on the studies of Alzheimer’s disease (AD). Experimental findings, advantages and disadvantages, and the prospect of every individual technique will be presented. MRI can be used to investigate the change of the brain in terms of volume, function, white matter track orientation and even mechanical properties and metabolic concentration.Results from volumetric and morphological analysis indicated that the hippocampus reduced by approximately 18%-24% or 3%-4% annually. Functional MRI (fMRI) detected the blood oxygen level dependent (BOLD) signaland suggested thatmedial temporal lobe (MTL) such as hippocampus and entorhinal cortex reduced at the early stage of AD, and frontal, temporal, and parietal cortices at the later stage. In diffusion tensor imaging (DTI), the white matter fiber track integrity is measured but the results are inconsistent. Besides,magnetic resonance spectroscopy (MRS), chemical shift imaging (CSI), arterial spin labeling (ASL), magnetic resonance elastography (MRE) and susceptibility weighted imaging (SWI) will also be included in this review.
Export Options
About this article
Cite this article as:
Wang Defeng, Hui CN Steve, Shi Lin, Huang Wen-hua, Wang Tianfu, Mok CT Vincent, Chu CW Winnie and Ahuja T Anil, Application of Multimodal MR Imaging on Studying Alzheimer's Disease: A Survey, Current Alzheimer Research 2013; 10 (8) . https://dx.doi.org/10.2174/15672050113109990150
DOI https://dx.doi.org/10.2174/15672050113109990150 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
HIV-1, HCV and Alcohol in the CNS: Potential Interactions and Effects on Neuroinflammation
Current HIV Research Tumor-Receptor Imaging in Breast Cancer: A Tool for Patient Selection and Response Monitoring
Current Molecular Medicine Treatment Integrity: An Unresolved Issue in Psychotherapy Research
Current Psychiatry Reviews Cannabinoids and Neuroprotection in Motor-Related Disorders
CNS & Neurological Disorders - Drug Targets Application of Hot Melt Extrusion Technology in the Development of Abuse-Deterrent Formulations: An Overview
Current Drug Delivery Off-Label Use of Sunitinib in Patients with Advanced, Epithelial Thyroid Cancer: A Retrospective Analysis
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Eating Disorder Symptoms and CYP2D6 Variation in Cuban Healthy Females: A Report from the Ibero-American Network of Pharmacogenetics
Current Pharmacogenomics and Personalized Medicine Therapeutic Approaches for Lysosomal Storage Diseases: A Patent Update
Recent Patents on CNS Drug Discovery (Discontinued) Role of Polyphenols in Diet and Nutrition-An Updated Review
Current Nutrition & Food Science The Evolution of Histamine H3 Antagonists/Inverse Agonists
Current Topics in Medicinal Chemistry Proteomic Analysis of Endothelin-1 Targets in the Regulation of Cardiomyocyte Proliferation
Current Topics in Medicinal Chemistry Conformational Changes of the Protein Domains Upon Binding with Carbon Nanotubes Studied by Molecular Dynamics Simulations
Current Physical Chemistry Quinoline: An Attractive Scaffold in Drug Design
Mini-Reviews in Medicinal Chemistry Folate Status and Depressive Symptoms in Reproductive-Age Women
Current Nutrition & Food Science A Systematic, Updated Review on the Antidepressant Agomelatine Focusing on its Melatonergic Modulation
Current Neuropharmacology Compassionate Confrontation Psychotherapy: Working with Gifted but Self-Destructive Adolescents in a Therapeutic Boarding School
Adolescent Psychiatry Antidepressant Properties of Substance P Antagonists: Relationship to Monoaminergic Mechanisms?
Current Drug Targets - CNS & Neurological Disorders Molecular Mechanisms Underlying Behavioral Effects of Cocaine: Lessons From Knockout Mice
Current Pharmacogenomics Synthesis and Biological Evaluation of Dihydroisoquinoline-2(1H)- Carbothioamide Derivatives as TRPV1 Antagonists
Letters in Drug Design & Discovery Activation of Melanocortin-4 Receptor by a Synthetic Agonist Inhibits Ethanolinduced Neuroinflammation in Rats
Current Pharmaceutical Design